Count | |
| 1 | |
| 5 | |
| 22 | |
| 18 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 5 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
| 2 | |
| 1 | |
| 8 | |
| 6 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 3 | |
| 7 | |
| 1 | |
| 2 | |
| 1 | |
| 10 | |
| 1 | |
| 2 | |
| 7 | |
| 4 | |
| 2 | |
| 2 | |
| 2 | |
| 7 | |
| 1 | |
| 1 | |
| 14 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 18 | |
| 1 | |
| 27 | |
| 5 | |
| 11 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Antiretroviral Therapy, Highly Active/adverse effects/methods | 3 |
| 2 | |
Antiretroviral Therapy, Highly Active/*adverse effects/methods | 3 |
Antiretroviral Therapy, Highly Active/adverse effects/*methods | 5 |
*Antiretroviral Therapy, Highly Active/adverse effects/methods | 1 |
Electric Stimulation Therapy/adverse effects/*instrumentation/*methods | 1 |
Antiretroviral Therapy, Highly Active/*adverse effects/utilization | 2 |
Salvage Therapy/adverse effects/*standards/statistics & numerical data | 1 |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 6 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 2 | |
| 15 | |
| 2 | |
| 1 | |
| 1 | |
| 5 | |
| 5 | |
| 2 | |
| 9 | |